August 10, 2001Cardiome Pharma Corp • April 26th, 2002 • Pharmaceutical preparations • New York
Company FiledApril 26th, 2002 Industry Jurisdiction
1 2 securities sold as part of such Investment at an exercise price equal to one- hundred-ten percent (110%) of the price of such securities, exercisable until five (5) years from the date of issuance of such warrants. For the purposes of this...Neoprobe Corp • April 12th, 1999 • In vitro & in vivo diagnostic substances • New York
Company FiledApril 12th, 1999 Industry Jurisdiction